3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| David, P; el Far, O; Martin-Mouto, N; Poupon, MF; Seagar, MJ; Takahashi, M | 1 |
| Kraveka, JM; Obeid, LM; Ogretmen, B; Schady, D | 1 |
2 other study(ies) available for 3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate and Lung Neoplasms
| Article | Year |
|---|---|
Expression of synaptotagmin and syntaxin associated with N-type calcium channels in small cell lung cancer.
Topics: Animals; Antibodies, Monoclonal; Antigens, Surface; Blotting, Western; Calcium Channels; Calcium-Binding Proteins; Carcinoma, Small Cell; Cholic Acids; Humans; Immunosorbent Techniques; Lung Neoplasms; Membrane Glycoproteins; Nerve Tissue Proteins; omega-Conotoxin GVIA; Peptides; Rats; Synaptotagmin I; Synaptotagmins; Syntaxin 1; Tumor Cells, Cultured | 1993 |
Immunoprecipitation of human telomerase reverse transcriptase with telomerase activity.
Topics: Antibodies; Cholic Acids; DNA-Binding Proteins; Humans; Lung Neoplasms; Precipitin Tests; RNA; Telomerase; Tumor Cells, Cultured | 2001 |